Borderline Left Ventricle in Critical Aortic Stenosis: Which Pathway?
A term 3.1 kg boy is admitted at 6 hours of age. Prenatal echocardiography showed severe aortic stenosis. On examination he has weak femoral pulses, mottled legs, and a lactate of 3.4 mmol/L. Pre-ductal SpO2 is 90% and post-ductal 86% on room air, and prostaglandin E1 is started at 0.03 mcg/kg/min. Bedside echocardiography shows an LV end-diastolic length of 21 mm, mitral annulus 4.8 mm (z-score -3.1), aortic annulus 5.4 mm (z-score -1.8), ejection fraction 20%, dense endocardial fibroelastosis, retrograde flow in the transverse aortic arch, and a small restrictive patent foramen ovale with left-to-right flow. The interventional team proposes balloon aortic valvotomy tomorrow; the surgical team raises hybrid stage I or Norwood. The family asks why the teams disagree.
1. Which echocardiographic and clinical variables most influence the biventricular versus univentricular decision, and what further information would you obtain before committing?
Read the worked answer
Variables that dominate the decision
- LV inflow and size: mitral annulus z-score near -3 is a strong negative predictor; LV length and LV/RV ratio matter more than the aortic annulus, which is only moderately small here.
- Myocardial quality: dense endocardial fibroelastosis predicts poor compliance and diastolic failure after valvotomy, even if the valve is opened successfully.
- Arch flow direction: retrograde transverse arch flow signals that the LV is not ejecting enough to supply the head and neck, favoring a univentricular pathway.
- Restrictive atrial septum: a small PFO with left-to-right flow already indicates elevated LV filling pressures.
- Clinical status: lactate 3.4 and mottled legs reflect systemic hypoperfusion; coronary perfusion depends on the ductus, so the child is ductal-dependent and unstable.
Additional data needed Repeat echocardiography after ductal stabilization, since measurements drift with loading conditions; coronary anatomy (fistulae, sinusoids); degree of mitral regurgitation and LVOT anatomy; renal and hepatic function; and, if needed, cardiac CT or catheterization for arch and coronary definition. Scoring systems (e.g., Rhodes, CHSS) inform but do not replace serial bedside assessment.
2. What are the specific risks of the prostaglandin E1 infusion in this child, and how would you manage them?
Read the worked answer
Risks and mitigation
- Apnea: common at 0.03 mcg/kg/min and above. Have airway equipment and intubation readiness at the bedside, particularly before transport; pre-emptive intubation is reasonable before transfer.
- Systemic vasodilation and hypotension: opening the ductus in critical aortic stenosis can lower diastolic pressure and reduce coronary perfusion, precipitating ischemia in a ventricle already at 20% EF. Titrate to the lowest dose that maintains ductal patency; accept partial patency; support with volume, cautious inotropy, and avoid unnecessary afterload reduction.
- Pulmonary overcirculation: ductal flow to the lungs can cause pulmonary edema and steal from the systemic circulation; monitor saturations, liver size, and gases.
- Other effects: fever, jitteriness, and with prolonged use cortical hyperostosis and electrolyte disturbance.
- Surveillance: continuous arterial line, serial lactate, urine output, and repeat echocardiography; have a low threshold to escalate to the catheterization laboratory if perfusion deteriorates.
3. How do you frame the disagreement for the family and structure the decision?
Read the worked answer
Framing
- Name the uncertainty explicitly: the disagreement reflects a genuinely borderline ventricle, not carelessness. Explain that both teams agree on stabilizing him first and that today's decision is about a pathway, revisable later.
- Present the options with honest probabilities: valvotomy as a bridge that tests whether the LV can sustain systemic output (with a pre-agreed conversion plan), versus committing early to a staged single-ventricle pathway.
- Describe what each path means for the child's life: number of operations, catheterizations, anticoagulation, exercise capacity, Fontan-associated risks, and neurodevelopmental outcomes.
Process
- Hold a joint conference with interventional cardiology, surgery, intensive care, and nursing, and document the consensus and dissent.
- Use a shared decision-making framework with teach-back; involve the family's values about risk and repeated hospitalization.
- Reassess after 24-48 hours of stabilization; involve palliative care supportively, not as an alternative to treatment.
- Agree in advance on triggers for abandoning a biventricular attempt, and on how the family will be told.